GRMN
62
-3
AIV
68
-4
DE
46
3
ADP
64
2
AVGO
20
-5
TRV
53
-3
JWN
40
-2
LLY
39
9
ZTS
47
2
KMX
58
3
DLTR
34
-4
HAS
30
2
HD
47
-5
XEL
67
2
EOG
58
2
CAG
30
4
VRTX
46
2
PSA
51
-4
SYF
85
2
ZBH
60
-2
GRMN
62
-3
AIV
68
-4
DE
46
3
ADP
64
2
AVGO
20
-5
TRV
53
-3
JWN
40
-2
LLY
39
9
ZTS
47
2
KMX
58
3
DLTR
34
-4
HAS
30
2
HD
47
-5
XEL
67
2
EOG
58
2
CAG
30
4
VRTX
46
2
PSA
51
-4
SYF
85
2
ZBH
60
-2
Financhill
Back

Universe Pharmaceuticals 10K Form

Buy
60

UPC
Universe Pharmaceuticals

Last Price:
1.78
Seasonality Move:
-19.07%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive UPC News And Ratings

See the #1 stock for the next 7 days that we like better than UPC

UPC Financial Statistics

Sales & Book Value

Annual Sales: $32.31M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $110.01
Price / Book: 0.13

Profitability

EPS (TTM): -76.35000
Net Income (TTM): $-18.55M
Gross Margin: $10.32M
Return on Equity: -49.07%
Return on Assets: -32.15%

Universe Pharmaceuticals Earnings Forecast

Key Universe Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 6 years for UPC is 31.93%.
  • The Selling, General & Administrative Expenses for UPC have been equal to 27.86% of Gross Profit Margin.
  • The Research & Development expenses have been 15.04% of Revenue.
  • The Interest Expense is -2.54% of Operating Income.
  • The Net Earning history of UPC is -19.08% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

Universe Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: UPC
Website: universe-pharmacy.com

Debt

Debt-to-Equity Ratio: 0.24
Current Ratio: 1.63
Quick Ratio: 1.25

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

UPC Technical Analysis vs Fundamental Analysis

Buy
60
Universe Pharmaceuticals (UPC) is a Buy

Is Universe Pharmaceuticals a Buy or a Sell?